Contributor Page
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 202 4084000
Fax: +1 202 4084400
901 New York Avenue, NW
Washington, DC
20001-4413
United States
By Ashley Winkler, M. David Weingarten, Shana Cyr
NDAs must be accompanied by certain patent information, which the FDA then lists in its Approved Drug Products with Therapeutic Equivalence Evaluations publication.
By Shrey Pathak, Sanam Habib
On 12 July, the UK Government published its 'White Paper' for Brexit. In the policy paper titled "The future relationship between the United Kingdom and the European Union
By Barbara McCurdy, Arpita Bhattacharyya Ph.D.
The possibility of estoppel is an important consideration for a defendant in a patent infringement action in deciding whether or not to file an inter partes review petition. Indeed...
By Barbara McCurdy, Jill MacAlpine, Amanda Murphy, Thomas Irving
Before the American Invents Act, the U.S. had a "first-to-invent" patent system. That system included provisions for resolving disputes concerning who was the first to invent ...
By John Paul, Brian Kacedon, M. David Weingarten
The U.S. Court of Appeals for the Federal Circuit determined that a Brazilian corporation that installed infringing conveyor systems on a U.S.-flagged ship could be sued for patent infringement...
By John Paul, Brian Kacedon, Cecilia Sanabria
A state's sovereign immunity does not allow its agencies to avoid the requirements of the patent venue statute.
By John Paul, Brian Kacedon, Robert MacKichan III
A corporation is not a resident of every district in the state of incorporation for purposes of the patent venue statute.
By David Seastrunk, Daniel Klodowski, Elliot Cook
Through June 15, 2018, the Federal Circuit decided 377 PTAB appeals from IPRs and CBMs.
In Sirona Dental Systems GmbH v. Institut Straumann AG, the Federal Circuit affirmed-in-part, vacated-in-part, and remanded-in-part the PTAB's decision.
By Elizabeth Ferrill, Margaret Esquenet
Software as a Medical Device–also referred to as SaMD–is one of the fastest growing innovations in the medical device industry
By Kathleen A. Daley
In this podcast, Finnegan partner Kathleen Daley offers insight into three recently-decided Federal Circuit cases and their potential implications:
Apple appeals from a Western District of Wisconsin jury decision, finding Apple vicariously liable for infringement of U.S. Patent No. 5,781,752 by Samsung, a third-party, and awarding the Wisconsin Alumni Research Fund ("WARF") $506 million in damages.
By Daniel Klodowski, David Seastrunk, Michael R Galgano
The Patent Trial and Appeal Board issued 34 IPR and CBM Final Written Decisions in May, including decisions following remands from the Federal Circuit...
By Danny Awdeh, Benjamin Tookey
The World Cup provides more gold than just the trophy won by the last team standing.
By Elizabeth Ferrill
Jenny Yoo Collection, Inc. v. Watters Designs, Inc. et al, Civil Action No. 3:17-cv-3197-M (N.D.Tex. June 6, 2018).
Contributor's Topics
More...